SPNE - SeaSpine announces full commercial launch of its WaveForm TO product for spinal procedures
SeaSpine (NASDAQ:SPNE), a maker of surgical solutions for the treatment of spinal disorders, on Wednesday announced the full commercial launch of its 3D-printed WaveForm TO Interbody System product. SPNE said its WaveForm TO product was designed to be used in two types of lumbar interbody fusion (LIF) procedures - posterior LIF and transforaminal LIF. The procedures involve using a back area incision approach to fuse the lumbar spine bones together. "WaveForm TO is our first 3D Interbody to commercially launch, with more launches planned before the end of this year,” said Dennis Cirino, SPNE's senior VP of global spinal systems. SPNE stock earlier closed marginally higher at $7.74.
For further details see:
SeaSpine announces full commercial launch of its WaveForm TO product for spinal procedures